Thomas Gad, See remarks at Y-mAbs Therapeutics, Inc. (YMAB), sold 562,340 shares at $7.01 ($4.0M) on 2022-02-08, disclosed to the SEC on 2022-02-09.
Open-market sale of $4.0M YMAB by See remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.59 | 91,031 | $691K | 17.1% |
| 2 | $7.59 | 91,031 | $691K | 17.1% |
| 3 | $7.01 | 125,863 | $882K | 21.8% |
| 4 | $7.01 | 125,863 | $882K | 21.8% |
| 5 | $6.96 | 64,276 | $447K | 11.1% |
| 6 | $6.96 | 64,276 |
| $447K |
| 11.1% |
| Total | $7.19 avg | 562,340 | $4.0M | 100% |
| Filing → |
| YMAB | SELL | 2024-06-11 | $841K | — | Filing → |
| YMAB | SELL | 2024-05-23 | $396K | — | Filing → |
| YMAB | SELL | 2024-03-07 | $128K | — | Filing → |